HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Damu Tang Selected Research

5- methyl- 1- (3- fluorophenyl)- 2- (1H)- pyridone

1/2022Fluorofenidone Inhibits UUO/IRI-Induced Renal Fibrosis by Reducing Mitochondrial Damage.
1/2014Fluorofenidone offers improved renoprotection at early interventions during the course of diabetic nephropathy in db/db mice via multiple pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Damu Tang Research Topics

Disease

23Neoplasms (Cancer)
12/2023 - 09/2004
13Breast Neoplasms (Breast Cancer)
06/2023 - 10/2008
13Prostatic Neoplasms (Prostate Cancer)
10/2021 - 11/2008
10Carcinogenesis
01/2023 - 08/2006
8Neoplasm Metastasis (Metastasis)
12/2021 - 01/2015
5Carcinoma (Carcinomatosis)
01/2020 - 08/2006
4Ataxia Telangiectasia (Louis Bar Syndrome)
04/2017 - 10/2006
4Renal Cell Carcinoma (Grawitz Tumor)
09/2014 - 10/2007
2Reperfusion Injury
01/2023 - 01/2022
2Inflammation (Inflammations)
01/2023 - 01/2019
2Fibrosis (Cirrhosis)
01/2022 - 11/2015
2Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2016 - 06/2010
2Atherosclerosis
05/2013 - 08/2003
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2023
1Melanoma (Melanoma, Malignant)
01/2023
1Glucose Intolerance
01/2023
1Acute Kidney Injury (Acute Renal Failure)
01/2023
1Type 2 Diabetes Mellitus (MODY)
01/2023
1Hepatocellular Carcinoma (Hepatoma)
01/2023
1Obesity
01/2023
1Starvation
01/2023
1Lymphatic Metastasis
06/2022
1Ureteral Obstruction
01/2022
1Disease Progression
01/2021
1Hyperphosphatemia
01/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2017
1Colonic Neoplasms (Colon Cancer)
01/2016
1Hypoxia (Hypoxemia)
09/2015
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2014

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
12/2021 - 10/2009
4Estrogen ReceptorsIBA
07/2019 - 01/2015
4Tumor Suppressor Protein p14ARF (p14ARF)IBA
11/2008 - 09/2004
3Biomarkers (Surrogate Marker)IBA
09/2023 - 12/2019
3RNA (Ribonucleic Acid)IBA
06/2023 - 01/2019
3AgarIBA
01/2023 - 08/2006
3CholesterolIBA
01/2023 - 05/2013
3Glucose (Dextrose)FDA LinkGeneric
01/2023 - 01/2013
3Contactin 1IBA
10/2021 - 03/2016
3TamoxifenFDA LinkGeneric
10/2018 - 01/2015
3sharpinIBA
03/2018 - 01/2015
3Messenger RNA (mRNA)IBA
03/2017 - 01/2015
3hematoporphyrin monomethyl etherIBA
06/2016 - 06/2011
3Cadherins (E-Cadherin)IBA
03/2016 - 06/2012
3AndrogensIBA
11/2015 - 11/2008
2taxaneIBA
12/2023 - 10/2014
2taxifolinIBA
09/2023 - 06/2023
2Immune Checkpoint InhibitorsIBA
09/2023 - 01/2023
2PeroxiredoxinsIBA
01/2023 - 11/2015
25- methyl- 1- (3- fluorophenyl)- 2- (1H)- pyridoneIBA
01/2022 - 01/2014
2raf KinasesIBA
12/2021 - 09/2014
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2020 - 01/2013
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2020 - 11/2009
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2019 - 06/2010
2TensinsIBA
12/2019 - 06/2010
2CytokinesIBA
01/2019 - 05/2013
2Hormones (Hormone)IBA
03/2018 - 11/2017
2Etoposide (VP 16)FDA LinkGeneric
04/2017 - 10/2014
21-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2016 - 12/2013
2Pyruvate KinaseIBA
09/2015 - 08/2014
2Phosphotransferases (Kinase)IBA
12/2013 - 10/2006
2LipidsIBA
05/2013 - 01/2013
2Apolipoproteins E (ApoE)IBA
05/2013 - 08/2003
2HomocysteineIBA
08/2004 - 08/2003
1RELTIBA
12/2023
1LDL Receptors (LDL Receptor)IBA
01/2023
1Fas Ligand Protein (Fas Ligand)IBA
01/2023
1LipopolysaccharidesIBA
01/2023
1LuciferasesIBA
01/2023
1Triglycerides (Triacylglycerol)IBA
01/2023
1Transforming Growth Factor-beta Type I ReceptorIBA
06/2022
1Mitochondrial DNA (mtDNA)IBA
01/2022
1AutoantibodiesIBA
01/2021
1Cell Adhesion MoleculesIBA
01/2020
1Mn(III) 5,10,15,20- tetrakis(N- methylpyridinium- 2- yl)porphyrinIBA
01/2020
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2020
1Vascular Endothelial Growth Factor CIBA
01/2020
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2020
1Growth Factor ReceptorsIBA
12/2019
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2019
1ButyrylcholinesteraseIBA
08/2018
1Histones (Histone)IBA
04/2017
1Serine (L-Serine)FDA Link
04/2017
1Proline (L-Proline)FDA Link
01/2016
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2016
1Arginine (L-Arginine)FDA Link
01/2016
1enzalutamideIBA
11/2015
1abirateroneIBA
11/2015
1Cysteine (L-Cysteine)FDA Link
09/2015
1Tyrosine (L-Tyrosine)FDA Link
09/2015
1Progesterone Receptors (Progesterone Receptor)IBA
01/2015
1Estrogen Receptor alphaIBA
01/2015
1ProgesteroneFDA LinkGeneric
01/2015
1Docetaxel (Taxotere)FDA Link
10/2014
1DNA (Deoxyribonucleic Acid)IBA
12/2013

Therapy/Procedure

10Therapeutics
12/2023 - 10/2014
8Castration
12/2023 - 10/2014
2Lasers (Laser)
06/2016 - 06/2011
1Intraperitoneal Injections
01/2019
1Photochemotherapy (Photodynamic Therapy)
06/2016
1Prostatectomy (Retropubic Prostatectomy)
03/2016